Medical devices, healthcare technology and the business of care
510(k) clearance · K261521

Sleep Analysis Module

Neurotronics, LLC · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK261521

What did the FDA decide?

FDA recorded a substantial equivalence decision (SESE) for K261521, the Sleep Analysis Module submitted by Neurotronics, LLC of Alachua, Florida. The decision date is 2026-10-09 and the application was received 05/07/2026, per the agency's 510(k) listing. The record carries product code OLZ and specialty Neurology, and one FDA page associates the submission with automatic event detection software for polysomnography with electroencephalograph.

Under 510(k) review, SESE denotes clearance of the submitted device as substantially equivalent to a predicate, not premarket approval of a new system. The record does not identify the predicate device, the specific software functions or components assessed, or any performance data, so the technical basis for the equivalence finding remains unknown. No summary statement is included in the supplied data, and no clinical or labeling conclusions should be drawn from the decision alone.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261521
Regulatory pathway
510(k) premarket notification
Product code
OLZ
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automatic Event Detection Software For Polysomnograph With Electroencephalograph.

Product code
OLZ
FDA device class
2

FDA decision timeline

  1. K261521 received

    Application receipt date recorded by FDA.

  2. K261521 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Neurotronics, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Alachua, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records